<DOC>
	<DOCNO>NCT01000051</DOCNO>
	<brief_summary>The goal clinical research study learn eltrombopag help improve platelet count patient low platelet stem cell transplant . The safety drug also study .</brief_summary>
	<brief_title>Eltrombopag Post Transplant Thrombocytopenia</brief_title>
	<detailed_description>The Study Drug : Platelets cell help blood clot . Platelet count often low receive stem cell transplant . When number platelet body get low , cause bleeding . Eltrombopag design imitate protein body help make platelet . This may help platelet count stay normal . Study Groups : If find eligible take part study , randomly assign ( flip coin ) 1 2 study group : - If Group 1 , receive eltrombopag . - If Group 2 , receive placebo . A placebo substance look like study drug active ingredient . If 1 first 20 participant enrol study , equal chance assign either group . If join study 20 participant enrol , good chance assign Group 1 eltrombopag show effective . Neither study staff know receive study drug placebo . However , need safety , study staff able find receiving . Study Drug Administration : You take study drug/placebo pill mouth 1 time day study . The study drug/placebo take empty stomach ( 1 hour 2 hour food/drink ) . You may drink water , coffee , and/or tea study drug/placebo . You drink coffee tea without milk cream . The dose study drug/placebo may adjust ( raise lower ) throughout study base reaction study drug/placebo . Study Visits : Every 2 week , follow test procedure perform : - You physical exam , include measurement weight vital sign . - You ask side effect may . - Blood ( 2 tablespoon ) draw routine test . - Blood ( 1 teaspoon ) drawn PK testing . - Blood ( 1 tablespoon ) drawn check immune system . If blood test show may fiber deposit ( build-up ) bone marrow , bone marrow biopsy check status disease If symptom cataract ( cloud lens eye ) anytime study , eye exam . Length Study : You take study drug 8 week . You study visit 12 week . You take study intolerable side effect . End-of-Treatment Visit : After completion study drug , follow test procedure perform : - You physical exam , include measurement weight vital sign . - You ask side effect may . - Blood ( 3 tablespoon ) draw routine test . - Blood ( 1 tablespoon ) drawn check blood 's clotting ability . - Blood ( 1 tablespoon ) drawn check immune system . Weeks 10 12 ( +/- 3 day ) , follow test procedure perform : - You telephone interview . - You ask side effect may . - Blood ( 3 tablespoon ) draw routine test . - Blood ( 1 tablespoon ) drawn check blood 's clotting ability . - You either blood draw locally live regionally . Within 3 month last dose study drug , bone marrow biopsy check status disease eye exam . The eye exam may perform sooner develop symptom cataract , blurry vision . This investigational study . Eltrombopag FDA approve commercially available treatment low platelet count patient idiopathic thrombocytopenic purpura ( ITP -- severe bleed disease ) . Its use patient low platelet count stem cell transplant investigational . Up 64 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<criteria>1 . Patients &gt; /= 35 day post HCT Platelet count &lt; /= 20 x 10^9/l sustain 7 day patient platelet transfusion dependent , 2 . Neutrophil count &gt; /= 1.5 x 10^9/l anytime within last seven day enrollment . Patients myeloid erythroid growth factor example filgrastim ) , 3 . Age &gt; /= 18 1 . Recurrence progression primary malignancy HCT 2 . ALT &gt; /= 2.5 time ULN 3 . Serum bilirubin &gt; 2mg/dl ( unless due Gilbert 's syndrome ) 4 . Documented deep vein thrombosis within 1 year enrollment study , except upper arm thrombosis related central venous catheter , within 3 month enrollment study . 5 . ECOG Performance status &gt; 2 6 . Pregnancy : Women childbearing potential men must agree use contraception prior study entry duration study participation . A woman childbearing potential define woman naturally postmenopausal least 12 consecutive month previous surgical sterilization . A negative pregnancy test result require study drug give .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Transplant Thrombocytopenia</keyword>
	<keyword>Hematopoietic cell transplantation</keyword>
	<keyword>HCT</keyword>
	<keyword>Low platelet count</keyword>
	<keyword>Bleeding</keyword>
	<keyword>Blood clot</keyword>
	<keyword>Stem Cell Transplant</keyword>
	<keyword>Blood And Marrow Transplantation</keyword>
	<keyword>Eltrombopag</keyword>
	<keyword>Promacta</keyword>
</DOC>